SPRED1 and cancer: The “missing” CMMRD cases may be identified by screening unselected pediatric cancer patients (Gröbner et al., 2018), and children suspected of NF1 or Legius syndrome who lack the causative NF1 or SPRED1 variants (Suerink et al., 2019).